Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH) (NCT04391114)
The Operative Parameters and Postoperative Outcomes of the Top-Down Holmium Laser Enucleation of the Prostate (HoLEP) Technique vs the Traditional HoLEP for Treatment of Benign Prostatic Hyperplasia (BPH): A Randomized Prospective Comparative Study
๐ฉบ Plain-English Summary (8th-Grade Level)
Benign prostatic hyperplasia (BPH), the non-malignant enlargement of the prostate gland, places pressure on the urethra and causes urination difficulties and bladder problems. Lower Urinary Tract Symptoms (LUTS) secondary to BPH is a common condition in aging men, with an overall prevalence of more than 50% in those older than 50 years of age. Men with LUTS often experience sexual dysfunction including ejaculatory loss, painful ejaculation, and erectile dysfunction, which among other complications can also lead to a decreased quality of life. Holmium laser enucleation of the prostate (HoLEP), first reported by Fraundorfer et al in 1998, is a more recent step in the evolution of holmium laser prostatectomy. HOLEP offers patients the alternative of being treated endoscopically with minimal blood loss, short catheterization time, and decreased hospital stay. One noted drawback to HoLEP, and the primary reason why it has yet to become the new standard for treatment of symptomatic BPH, is the complexity of this procedure, with a prolonged learning curve. Modifications to the procedure have thus been explored in order to address this limitation. The "Top-Down" HoLEP technique is a novel technique which offers potential benefits to the Traditional HoLEP procedure, including decreased complexity, a reduced learning curve, with anticipated improved continence. This study will compare the operating time between the Top-Down Holmium Laser Enucleation of the prostate (HoLEP) and the Traditional HoLEP for the treatment of patients with symptomatic bladder outlet obstruction due to BPH in Northwestern Ontario.
Who can join: Review the eligibility criteria below.
Location: Thunder Bay Regional Health Sciences Centre/Thunder Bay Regional Health Research Institute โ Thunder Bay, Ontario
Age range: 50 Years
๐งช Interventions in This Study
- Traditional HoLEP (PROCEDURE)
- Top-Down HoLEP (PROCEDURE)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Thunder Bay Regional Health Sciences Centre/Thunder Bay Regional Health Research Institute โ Thunder Bay, Ontario
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Benign Prostatic Hyperplasia
- PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs โ La Mesa, California
- Comparing UroLift Experience Against Rezลซm โ Los Angeles, California
- Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocrossยฎ Expander System & Retrieval Sheath โ Maywood, Illinois
- Optilumeโข BPH Catheter System in Men With Symptomatic BPH โ Little Rock, Arkansas
- Investigation of Prostate Artery Embolization Compared to Holmium Laser Enucleation of Prostate โ Miami, Florida
- Laser Prostatectomy Database and Registry โ Indianapolis, Indiana
Explore by condition: All Benign Prostatic Hyperplasia clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.